What kind of medicine is Anamorelin? Learn about its ingredients, uses and indications

Anamorelin is a new type of oral drug that is a selective growth hormone secretion agent that mainly works by stimulating the secretion of growth hormone (GH) in the body. It is a non-peptide small molecule that can selectively activate the growth hormone-releasing hormone receptor (GHRH-R), thereby promoting the secretion of endogenous growth hormone, ultimately achieving the effect of improving muscle mass and weight. Unlike traditional growth hormone treatments, Anamorelin works by enhancing the natural growth hormone secretion mechanism rather than directly injecting exogenous growth hormone.

The main use of anamorelin is to treat weight loss and muscle loss caused by cancer, especially in those receiving chemotherapy or radiation therapy for cancer. These patients often face cancer wasting disease (cancer cachexia), in which patients experience severe weight and muscle loss due to metabolic changes in the tumor. Anamorelin helps patients regain weight and build muscle mass by regulating growth hormone and insulin-like growth factor (IGF-1) levels, thereby improving patients' overall health and quality of life.

Anamorelin is widely used in the treatment of cancer wasting disease, especially in cancer patients with significant weight loss and severe loss of muscle mass. It is suitable for patients with multiple cancer types including non-small cell lung cancer, gastric cancer, colorectal cancer, etc. By replenishing growth hormone in the body, Anamorelin helps slow or reverse weight loss and muscle atrophy caused by cancer treatment, improves patients' tolerance and recovery capabilities, and helps them better complete cancer treatment.

Overall, anamorelin, as an oral drug, offers a novel, non-invasive way to improve cancer wasting in cancer treatment. Compared with traditional treatment methods, it regulates the endocrine system more directly, helping patients regain weight and gain strength, thereby improving quality of life. However, the use of anamorelin should be done under the guidance of a doctor, as it may cause some side effects, such as edema, insulin resistance, etc., and the patient's response needs to be closely monitored.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/